235 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Friday’s Close
IONS Ionis Pharmaceuticals, Inc. $48.21 $6.62B N/A
Article Searches
4 Large-Cap Stocks Worth Looking Into Right Now http://www.zacks.com/stock/news/388148/4-large-cap-stocks-worth-looking-into-right-now?cid=CS-ZC-FT-388148 Apr 18, 2019 - Here are 4 large-cap stocks from varied industries that may be worth your money.
Ion Geophysical (IO) Reports Q1 Loss, Tops Revenue Estimates http://www.zacks.com/stock/news/407018/ion-geophysical-io-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-407018 May 01, 2019 - Ion Geophysical (IO) delivered earnings and revenue surprises of -97.40% and 8.06%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Ionis Pharmaceuticals (IONS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release http://www.zacks.com/stock/news/407704/ionis-pharmaceuticals-ions-earnings-expected-to-grow-what-to-know-ahead-of-next-weeks-release?cid=CS-ZC-FT-407704 May 02, 2019 - Ionis Pharmaceuticals (IONS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Biogen's New Study to Test Higher Dose of SMA Drug Spinraza http://www.zacks.com/stock/news/526375/biogens-new-study-to-test-higher-dose-of-sma-drug-spinraza?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-526375 Sep 19, 2019 - Biogen (BIIB) starts a DEVOTE study to investigate whether a higher dose of Spinraza can provide greater efficacy for treating patients with spinal muscular atrophy.
Ionis Pharmaceuticals (IONS) Q3 Earnings and Revenues Beat Estimates http://www.zacks.com/stock/news/606213/ionis-pharmaceuticals-ions-q3-earnings-and-revenues-beat-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-606213 Nov 06, 2019 - Ionis Pharmaceuticals (IONS) delivered earnings and revenue surprises of 158.06% and 11.66%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Pages: 1...192021222324

<<<Page 24